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Objective: Examine whether there are independent influences of a greater degree of adiposity and longer
duration of obesity on cardiac structure and function.
Methods: Participants of CARDIA were 18-30 years when they underwent a baseline examination in
1985-86. Seven follow-up examinations were conducted every 2-5 years.
Results: Among 2,547 participants who underwent an echocardiogram at the year 25 examination and
were not obese at baseline, 34.4 and 35.5% were overall (BMI30 kg m22) and abdominally obese
(waist circumference: men: >102 cm; women: >88 cm) at year 25, respectively. A greater degree of over-
all and abdominal adiposity at year 25 were each associated with a greater left ventricular (LV) mass
(P< 0.001), LV volume (P< 0.001), LV mass-to-volume ratio (P< 0.001), left atrial dimension (P< 0.001),
and ejection fraction (P<0.05) after adjustment for duration of obesity and other risk factors. In contrast,
a longer duration of overall obesity was associated with a greater LV mass (P5 0.003) and a trend for a
lower ejection fraction (P5 0.07).
Conclusions: A greater degree of adiposity is strongly associated with concentric LV remodeling in mid-
life, while the cumulative effects of a longer duration of overall obesity during young adulthood contribute
to concentric remodeling predominantly by increasing LV mass.
Obesity (2014) 22, 2434–2440. doi:10.1002/oby.20865
Introduction
Obesity has been linked to a spectrum of cardiovascular changes
ranging from a hyperdynamic circulation, through subclinical car-
diac structural changes to overt heart failure (1-3). Existing studies
have shown that left ventricular (LV) hypertrophy, LV systolic
function, and LV diastolic function worsen with a greater degree
of overall and abdominal adiposity (5). Recent evidence also sug-
gests obesity is associated with a greater LV mass to a greater
extent than chamber size (6-8). While the pattern of remodeling
associated with a greater degree of adiposity has been documented,
little information exists on the consequences of a longer duration
of obesity.
Understanding the consequences of a longer duration of obesity is
critical, given the obesity epidemic. With a doubling of obesity rates
for adults and a tripling of rates for children and adolescents over
the last three decades, younger individuals are experiencing a greater
degree and longer duration of exposure to excess adiposity over
their lifetime (9,10). Preliminary data suggest that a longer duration
of obesity contributes to a greater LV mass and worse LV function
in most (11-13), but not all studies (14). Important limitations of
these studies include small clinic-based samples, lack of simultane-
ous adjustment for the degree of adiposity, and the dependence upon
the recall of body weight at previous ages to determine the duration
of obesity, a methodology that may be susceptible to a substantial
amount of measurement error.
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The present study was conducted to examine whether there are inde-
pendent influences of a greater degree of adiposity and longer dura-
tion of obesity beginning in early adulthood as a result of the obe-
sity epidemic on cardiac structure and function measured via
echocardiography in middle-age. Participants were black and white
adults recruited in 1985-1986 as part of the Coronary Artery Risk
Development in Young Adults (CARDIA) Study. The CARDIA
Study provided an ideal setting in which to address this question
because participants were recruited and followed largely during the
obesity epidemic of the last three decades in the United States as
well as during the period of greatest gain in adiposity during the life
course (9,15).
Methods
Study sample
CARDIA is a multicenter community-based longitudinal cohort
study of the development and determinants of cardiovascular disease
over time in 5,115 young adults initially aged 18-30 years in 1985-
1986. Black and white adults were recruited from four cities in the
United States with population-based samples approximately balanced
within center by sex, age, race, and education. To date, participants
have been re-examined 2, 5, 7, 10, 15, 20, and 25 years after base-
line and retention rates across examinations were 91, 86, 81, 79, 74,
72, and 72%, respectively.
Of the 3,498 participants who completed the year 25 follow-up
examination, we excluded those who did not complete an echocar-
diogram (n5 24) and those without available measures of cardiac
structure and function (n5 353); those who were overall [body mass
index (BMI) 30 kg m22] or abdominally obese (>102 cm in men
and >88 cm in women (16)) at baseline (n5 341); were pregnant
during any examination (n5 160); those who experienced angina, a
myocardial infarction, or heart failure during follow-up (n5 54);
and those who had bariatric surgery (n5 19). The remaining 2,547
participants formed the sample population for analysis.
Clinical measurements
Standardized protocols for data collection were used across study
centers and examinations. Participants were asked to fast for at least
12 h and to avoid smoking or engaging in heavy physical activity
for at least 2 h before each examination.
Anthropometry
Weight and height were measured with participants wearing light
examination clothes and no shoes. Body weight was measured to the
nearest 0.2 kg with a calibrated balance-beam scale. Height was meas-
ured with a vertical ruler to the nearest 0.5 cm. BMI was calculated as
weight in kilograms divided by height in meters squared. Waist cir-
cumference was measured with a tape in duplicate to the nearest
0.5 cm around the minimal abdominal girth identified laterally mid-
way between the iliac crest and the lowest portion of the rib cage and
anteriorly midway between the xiphoid process and the umbilicus.
Duration of overall and abdominal obesity
For each participant, the number of years of overall and abdominal
obesity was calculated separately based upon the presence (or
absence) of overall or abdominal obesity at each follow-up examina-
tion and the preceding examination. For example, a participant who
was not overall obese at year 2, but was overall obese at year 5 and
all subsequent follow-up examinations was assigned 0 years of over-
all obesity at year 2, 3 years at year 5, 2 years at year 7, 3 years at
year 10, and so on. This scoring methodology was applied at each
follow-up examination and the cumulative duration of obesity across
examination years for each participant was then calculated (17).
Echocardiography
Echocardiography was performed at year 25 using an Artida cardiac
ultrasound machine (Toshiba Medical Systems, Tokyo, Japan) and a
previously described protocol (18,19). Briefly, sonographers at each
field center underwent initial, centralized training followed by qual-
ity assurance and control procedures to assess intra- and inter-
sonographer reproducibility. Measurements of LV and left atrium
(LA) dimensions were acquired from two-dimensional (2D)-guided
M-mode echocardiograms obtained from optimized parasternal
short-axis views. Studies were electronically transmitted to a core
reading laboratory at Johns Hopkins University. LV mass was calcu-
lated using the Devereux formula (20). LV end-diastolic volume
was acquired from a 2D four-chamber view. Mass-to-volume ratio
was calculated as the ratio of LV mass to end-diastolic volume.
Ejection fraction was calculated as the ratio of stroke volume to
end-diastolic volume. Heart rate was recorded from the electrocar-
diogram during the echocardiographic examination. Quality control
procedures included participant re-examination and blind re-reading
to allow assessment of intra- and inter-sonographer variability and
intra- and inter-reader variability, respectively. Technical errors for
intra- and inter-sonographer variability ranged from 5 to 11% and 6
to 12%, respectively. Intra- and inter-reader variability ranged from
3 to 9% and 6 to 11%, respectively.
The assessment of other measurements can be found in the Support-
ing Information.
Statistical analysis
Participant characteristics overall, and according to the degree of
adiposity and duration of obesity were described using means,
medians, and proportions as appropriate. Differences and trends
were tested using linear regression models and v2 analyses for con-
tinuous and categorical characteristics, respectively. The Kruskal–
Wallis test was used for characteristics with skewed distributions.
Multivariable linear regression models were used to estimate the
association between the degree of adiposity at year 25 and duration
of obesity with each of the measures of cardiac structure and func-
tion. The degree of adiposity and duration of obesity were modeled
in one of two exposure forms: as continuous variables assuming a
linear dose-response association, and as five-level categorical varia-
bles for overall and abdominal (i.e., sex-specific quintiles) adiposity
and a six-level categorical variable for duration of obesity. Models
were simultaneously adjusted for degree of adiposity and duration of
obesity. Analyses were further adjusted for age, sex, race, educa-
tional attainment, CARDIA field center, smoking, and average phys-
ical activity and alcohol intake during follow-up. A second model
adjusted additionally for use of antihypertensive medication, diabe-
tes, heart rate, and average systolic blood pressure during follow-up.
The additional adjustment variables in the second model could be in
the causal pathway; we regarded these models as possibly
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explanatory. Models using BMI as an exposure did not additionally
adjust for height. Tests for a linear trend were performed by entering
the degree of adiposity or duration of obesity into the multivariable
models as a continuous variable. Potential effect modification by
race-sex was explored in stratified analyses and evaluated by testing
the statistical significance of multiplicative interaction terms in mod-
els that also included lower-order terms.
In a sensitivity analysis, we determined the influence of missing
BMI and waist circumference values (7.8% of all measurements for
each) on the associations between the degree of adiposity and
duration of obesity with measures of cardiac structure and function.
Multiple imputation was used to impute missing BMI and waist cir-
cumference values using the sequential regression imputation
approach that is implemented in the software package IVEware (21).
Five datasets were generated using all available BMI and waist cir-
cumference data. Each data set was analyzed separately and results
from the five analyses were combined using the rules of Little and
Rubin (22).
Tests of statistical significance were two-tailed, with an alpha level
of 0.05. Because of the increased number of formal tests of interac-
tion, statistical significance for effect modification was defined at an
alpha level of 0.01. SAS version 9.3 (SAS Institute, Cary, NC) was
used to perform all analyses.
Results
Of the 2,547 eligible participants, 44.4% were black and 53.0%
were women. At year 25, the prevalence of a BMI <18.5, 18.5-
24.9, 25.0-29.9, 30.0-34.9, and 35.0 kg m22 was 0.9, 28.8, 35.9,
21.9, and 12.5, respectively. The prevalence of abdominal obesity at
year 25 was 35.5%. The average duration of overall and abdominal
obesity during follow-up was 14.1 (SD5 6.7) and 12.7 (SD5 6.3)
years, respectively. Mean age at onset of obesity was 36.1
(SD5 8.1) and 38.3 (SD5 7.6) years, respectively. The prevalence
of overall obesity duration of 1-5, 6-10, 11-15, 16-20, and >20
years was 8.4, 7.4, 8.0, 8.2, and 7.1%, respectively. For abdominal
obesity duration, these estimates were 11.3, 8.7, 8.0, 7.9, and 4.4%,
respectively.
Those with a longer exposure to overall obesity were more likely to
be younger at baseline, black, achieve less education, have a higher
average waist circumference during follow-up, and were less physi-
cally active and consumed less alcohol during follow-up (Table 1).
In addition, a longer duration of obesity was associated with a
higher heart rate, average blood pressures, glucose and insulin lev-
els, and were more likely to use antihypertensive medication and
have diabetes. Sex and smoking were unrelated to obesity duration.
Similar results were observed when the duration of overall obesity
was replaced with the degree of overall obesity, degree of
TABLE 1 Participant characteristicsa according to duration of overall obesityb in 5-year increments, The CARDIA Study
(n52,547)
Variablea
Duration of overall obesity (years)
P
trend
0
(n5 1,552)
1–5
(n5215)
6–10
(n5188)
11–15
(n5 203)
16–20
(n5 208)
>20
(n5 181)
Selected characteristics
Baseline age (years) 25.1 (3.5) 24.5 (3.5) 25.1 (3.6) 24.9 (3.8) 24.2 (3.8) 24.8 (3.6) 0.003
Women, % (n) 51.7 (802) 54.4 (117) 54.3 (102) 54.7 (111) 54.8 (114) 58.0 (105) 0.07
Black race, % 35.4 (550) 49.3 (106) 53.2 (100) 58.6 (119) 61.5 (128) 70.7 (128) <0.001
Educational attainment (years) 16.0 (2.6) 15.7 (2.5) 15.5 (2.6) 15.6 (2.6) 15.5 (2.5) 15.1 (2.4) <0.001
Ever smoker, % (n) 39.0 (605) 41.4 (89) 39.4 (74) 34.5 (70) 36.1 (75) 33.7 (61) 0.09
Physical activity (exercise units)c 366 (243524) 324 (200511) 316 (205474) 293 (176477) 289 (186454) 273 (152428) <0.001
Alcohol (ml day21)c 7.3 (1.617.2) 5.2 (0.716.4) 7.1 (1.017.0) 4.2 (0.611.3) 3.7 (0.412.8) 2.9 (0.310.6) <0.001
Clinical and physical characteristics
Body mass index (kg m22)c 23.3 (2.2) 26.5 (1.5) 27.4 (1.4) 28.7 (1.5) 30.6 (2.2) 33.4 (3.1) <0.001
Waist circumference (cm)c 77.7 (7.9) 84.2 (7.1) 86.1 (7.3) 88.2 (7.3) 92.3 (7.6) 96.8 (8.1) <0.001
Heart rate (bpm) 63.6 (10.4) 66.4 (10.2) 66.9 (9.6) 67.5 (10.3) 67.7 (10.4) 68.1 (10.6) <0.001
Systolic blood pressure (mm Hg)c 109.3 (9.2) 110.9 (9.4) 110.8 (8.5) 113.5 (9.2) 112.9 (8.5) 114.9 (8.7) <0.001
Diastolic blood pressure (mmHg)c 69.1 (7.1) 70.3 (6.6) 70.5 (6.3) 72.6 (7.2) 71.9 (6.6) 74.1 (6.5) <0.001
Ever antihypertensive medication, % (n) 15.7 (243) 28.4 (61) 23.9 (45) 32.5 (66) 31.7 (66) 44.8 (81) < 0.001
Ever diabetes, % (n)d 5.4 (83) 12.6 (27) 10.0 (18) 18.2 (37) 21.6 (45) 31.5 (57) <0.001
Fasting blood concentrationc
Glucose (mg dl21) 89.2 (8.4) 91.4 (10.6) 91.7 (10.4) 93.7 (12.1) 93.7 (11.7) 97.7 (15.9) < 0.001
Insulin (mU ml21) 9.6 (3.8) 12.8 (5.8) 13.2 (4.6) 14.4 (5.6) 16.0 (6.9) 17.9 (7.9) <0.001
aPresented as the mean (SD), median (IQR), or % (n) as appropriate.
bOverall obesity defined as a body mass index 30 kg m22.
cBased upon average values during follow-up.
dDiabetes defined as a self-report of oral hypoglycemic medications or insulin at examination years 2, 5, 7, 10, 15, 20, and 25; fasting glucose levels 7.0 mmol l21
(126 mg dl21) at examination years 7, 10, 15, 20, or 25; a 2-h postload glucose 11.1 mmol l21 (200 mg dl21) at examination years 10, 20, and 25; or a glycated
hemoglobin A1c 6.5% at years 20 and 25.
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abdominal obesity, and the duration of abdominal obesity except
there was no association of age at baseline with the degree of
abdominal adiposity or duration of abdominal obesity, and women
were more likely to have a longer duration of abdominal obesity
(data not shown).
Mean (SD) LV mass, LV end-diastolic volume, LV mass-to-volume
ratio, LA dimension, and ejection fraction were 164.0 (48.1) g,
126.0 (30.3) ml, 1.32 (0.32) g/ml, 3.66 (0.47) cm, and 69.6% (7.8),
respectively. A greater degree of overall adiposity at year 25 was
strongly associated with a greater LV mass, LV end-diastolic vol-
ume, LV mass-to-volume ratio, and LA dimension (P-trend <0.001,
for all) (Table 2). With each 5-U higher BMI, an 11.4 g greater LV
mass, a 5.9 ml greater LV end-diastolic volume, a 0.04 g ml21
higher LV mass-to-volume ratio, and a 0.2 cm larger LA was
observed. It was also associated with a higher ejection fraction
(0.5% higher with each 5-U higher BMI; P-trend 0.03). In contrast,
the duration of overall obesity was associated with a greater LV
mass (P-trend 0.003) and a lower ejection fraction that approached
statistical significance (P-trend 0.05). With each additional 5-years
of overall obesity, a 2.5 g greater LV mass and a 0.3% lower ejec-
tion fraction was observed. Adjustment for antihypertensive medica-
tion use, heart rate, average systolic blood pressure, and diabetes
during follow-up had minimal influence on these associations (Table
2; model 2). Results were also consistent when LV mass was
indexed to height2.7 (data not shown).
A greater degree of abdominal adiposity at year 25 was strongly
associated with a greater left ventricular mass, LV end-diastolic vol-
ume, LV mass-to-volume ratio, and LA dimension (P-trend <0.001,
for all) (Table 3). With each 10 cm higher waist circumference, an
11.0 g greater LV mass, a 4.0 ml greater LV end-diastolic volume,
a 0.05 g ml21 higher LV mass-to-volume ratio, and a 0.2 cm larger
LA was observed. Similarly, a greater degree of abdominal adiposity
was associated with a higher ejection fraction that approached statis-
tical significance (0.4% higher with each 10 cm higher waist cir-
cumference; P-trend 0.06). In contrast, the duration of abdominal
obesity was associated with a greater LV end-diastolic volume only
(P-trend 0.03). Adjustment for antihypertensive medication use,
heart rate, average systolic blood pressure, and diabetes during
follow-up had minimal influence on these associations (Table 3;
model 2).
Associations did not vary by race-sex except for the association of
the duration of overall obesity with LV mass-to-volume ratio (P-
interaction 0.007) and the degree of overall adiposity with LA
dimension (P-interaction <0.001). However, similar to findings in
the total sample, no association of the duration of overall obesity
with LV mass-to-volume ratio was observed within each race-sex
group [slope: 0.01, 20.02, 0.01, and 0.01 for black men, black
women, white men, and white women, respectively (P >0.2, for
all), per 5-year longer duration of overall obesity]. Measures of
association were in a similar direction for the association of the
TABLE 2 Mean (standard error) left ventricular mass, left ventricular end-diastolic volume, left atrial dimension, and ejection
fraction according to body mass index (BMI) at year 25 and duration of overall obesitya during follow-up, The CARDIA
Study (n52,547)
Left ventricular
mass (g)
Left ventricular
end-diastolic
volume (ml)
Left ventricular
mass-to-volume
ratio (g ml21)
Left atrial
dimension (cm)
Ejection
fraction (%)
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
BMI (kg m22)
<18.5 146.9 (8.7) 149.5 (8.6) 115.4 (6.0) 115.2 (6.0) 1.28 (0.07) 1.30 (0.07) 3.3 (0.09) 3.3 (0.09) 69.5 (1.7) 69.7 (1.7)
18.5–24.9 164.3 (3.7) 163.6 (3.7) 127.5 (2.5) 126.7 (2.6) 1.30 (0.03) 1.31 (0.03) 3.6 (0.04) 3.6 (0.04) 68.4 (0.7) 68.3 (0.7)
25.0–29.9 179.8 (3.3) 178.3 (3.3) 136.4 (2.3) 135.5 (2.3) 1.35 (0.03) 1.35 (0.03) 3.8 (0.03) 3.8 (0.04) 69.1 (0.7) 69.0 (0.7)
30.0–34.9 177.9 (2.0) 177.6 (2.2) 129.3 (1.4) 128.7 (1.5) 1.40 (0.02) 1.40 (0.02) 3.8 (0.02) 3.8 (0.02) 69.8 (0.4) 69.8 (0.4)
35.0 186.8 (2.8) 186.2 (3.0) 136.2 (2.0) 136.0 (2.1) 1.40 (0.02) 1.40 (0.02) 3.9 (0.03) 3.9 (0.03) 70.1 (0.6) 70.0 (0.6)
P trend <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.03 0.04
Per 5 kg m22 11.4 (1.2) 11.2 (1.2) 5.9 (0.8) 6.2 (0.8) 0.04 (0.01) 0.03 (0.01) 0.2 (0.01) 0.2 (0.01) 0.5 (0.2) 0.5 (0.2)
Duration of overall obesity (years)a
0 155.3 (2.6) 156.1 (2.9) 118.5 (1.8) 117.4 (2.0) 1.33 (0.02) 1.35 (0.02) 3.5 (0.03) 3.5 (0.03) 70.1 (0.5) 70.1 (0.6)
1–5 161.9 (3.6) 162.2 (3.6) 126.6 (2.5) 126.2 (2.5) 1.30 (0.03) 1.31 (0.03) 3.6 (0.04) 3.6 (0.04) 70.0 (0.7) 69.9 (0.7)
6–10 169.9 (3.8) 170.7 (3.9) 127.6 (2.6) 127.2 (2.7) 1.34 (0.03) 1.36 (0.03) 3.7 (0.04) 3.7 (0.04) 69.7 (0.7) 69.8 (0.8)
11–15 173.7 (3.8) 172.9 (3.9) 130.8 (2.7) 130.3 (2.7) 1.34 (0.03) 1.34 (0.03) 3.7 (0.04) 3.7 (0.04) 69.4 (0.8) 69.3 (0.8)
16–20 183.9 (4.0) 183.6 (4.1) 133.9 (2.8) 133.5 (2.8) 1.40 (0.03) 1.40 (0.03) 3.7 (0.04) 3.7 (0.04) 68.2 (0.8) 68.3 (0.8)
>20 182.1 (4.4) 180.7 (4.4) 136.4 (3.0) 136.0 (3.0) 1.35 (0.03) 1.35 (0.03) 3.8 (0.05) 3.8 (0.05) 68.8 (0.9) 68.8 (0.9)
P-trend 0.003 0.003 0.17 0.11 0.32 0.46 0.23 0.23 0.05 0.07
Per 5 years 2.5 (0.8) 2.5 (0.8) 0.8 (0.6) 0.9 (0.6) 0.01 (0.01) 0.004 (0.007) 0.01 (0.01) 0.01 (0.01) 20.3 (0.2) 20.3 (0.2)
Model 1 simultaneously adjusts for BMI at year 25 (kg m22) and duration of overall obesity (years) as well as age, sex, race, educational attainment, study center, current
smoking, and average physical activity and alcohol intake during follow-up. Model 2 adjusts additionally for use of antihypertensive medication, diabetes, heart rate, and
average systolic blood pressure during follow-up.
aOverall obesity defined as a body mass index 30 kg m22.
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degree of overall adiposity with LA dimension [slope: 0.17, 0.09,
0.01, 0.19 for black men, black women, white men, and white
women, respectively (P <0.001, for all), per 5-U higher BMI].
We observed similar results when we further adjusted for weight
change over the follow-up period (quintiles) and when we imputed
missing values using all available measures of BMI and waist cir-
cumference during follow-up on the sample of 2,547 participants
(data not shown).
Discussion
In this community-based sample of adults recruited and followed
largely during the obesity epidemic in the United States, a greater
degree of overall and abdominal adiposity were each strongly asso-
ciated with numerous measures of cardiac structure, including a
greater left ventricular mass, left ventricular end diastolic volume,
and left atrial dimension. A greater LV mass-to-volume ratio sug-
gested an adverse pattern of concentric LV remodeling with a
greater degree of adiposity. A longer duration of overall obesity, on
the other hand, was strongly associated with a greater LV mass.
These findings were independent of sociodemographic characteris-
tics, lifestyle behaviors, and other cardiovascular risk factors. In
addition, results did not vary consistently between white and black
men and women. These results suggest that a greater degree of adi-
posity is strongly associated with concentric LV remodeling in mid-
life, while the cumulative effects of a longer duration of overall obe-
sity during young adulthood may contribute to concentric
remodeling predominately by increasing LV mass.
Findings of the current study suggest that the degree of adiposity
may be a more important determinant of cardiac structure than a
longer duration of obesity. This was evidenced by strong dose-
response associations of the degree of overall and abdominal adipos-
ity with nearly all measures of LV structure and LA size. Obesity
has long been considered as a state of chronic volume overload
because the heart is required to circulate blood through the large
depot of adipose tissue (23). A greater degree of adiposity contrib-
utes to a higher cardiac output and workload, and a greater LV mass
(24,25). Early studies suggested that a greater degree of adiposity
was associated with eccentric LV remodeling (26). However, the
results of the current study as well as a number of other recent stud-
ies suggest a pattern of concentric LV remodeling whereby the LV
mass may increase to a greater extent than cavity size (higher LV
mass-to-volume ratio) (8,27).
Studies estimating the association of a longer duration of obesity on
cardiac structure have been mixed. These studies have relied exclu-
sively on the self-report of body weight at previous ages to deter-
mine the duration of obesity as opposed to the objective assessment
TABLE 3 Mean (standard error) left ventricular mass, left ventricular end-diastolic volume, left atrial dimension, and ejection
fraction according to waist circumference at year 25 and duration of abdominal obesitya during follow-up, The CARDIA
Study (n52,547)
Left ventricular
mass (g)
Left ventricular
end-diastolic
volume (ml)
Left ventricular
mass-to-volume
ratio (g ml21)
Left atrial
dimension (cm)
Ejection
fraction (%)
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
Waist circumference quintilesb
I 151.6 (3.3) 150.7 (3.4) 124.8 (2.3) 123.2 (2.4) 1.23 (0.03) 1.24 (0.03) 3.5 (0.03) 3.4 (0.04) 68.5 (0.7) 68.2 (0.7)
II 166.1 (3.2) 164.6 (3.3) 133.7 (2.2) 132.1 (2.3) 1.26 (0.03) 1.27 (0.03) 3.6 (0.03) 3.6 (0.04) 69.6 (0.7) 69.3 (0.7)
III 170.3 (2.9) 168.8 (3.0) 133.9 (2.0) 132.7 (2.1) 1.30 (0.02) 1.30 (0.02) 3.8 (0.03) 3.7 (0.03) 69.7 (0.6) 69.5 (0.6)
IV 175.6 (2.1) 174.8 (2.3) 131.7 (1.5) 131.2 (1.6) 1.36 (0.02) 1.36 (0.02) 3.8 (0.02) 3.8 (0.02) 69.5 (0.4) 69.3 (0.5)
V 189.0 (2.1) 189.1 (2.2) 132.8 (1.4) 133.2 (1.6) 1.44 (0.02) 1.44 (0.02) 3.9 (0.02) 3.9 (0.02) 70.0 (0.4) 70.0 (0.5)
P-trend <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.06 0.04
Per 10 cm 11.0 (1.0) 11.1 (1.0) 4.0 (0.7) 4.6 (0.1) 0.05 (0.008) 0.04 (0.008) 0.2 (0.01) 0.2 (0.01) 0.4 (0.2) 0.5 (0.2)
Duration of abdominal obesity (years)b
0 163.5 (1.7) 163.8 (2.1) 122.2 (1.2) 121.6 (1.4) 1.36 (0.01) 1.37 (0.02) 3.6 (0.02) 3.6 (0.02) 69.7 (0.3) 69.5 (0.4)
1–5 169.9 (2.6) 169.2 (2.8) 129.4 (1.8) 128.5 (1.9) 1.33 (0.02) 1.34 (0.02) 3.7 (0.03) 3.7 (0.03) 69.7 (0.5) 69.5 (0.6)
6–10 164.9 (3.0) 164.4 (3.2) 126.9 (2.1) 126.1 (2.2) 1.32 (0.02) 1.32 (0.03) 3.7 (0.03) 3.7 (0.03) 69.7 (0.6) 69.6 (0.7)
11–15 168.3 (3.4) 167.4 (3.5) 131.7 (2.4) 130.9 (2.4) 1.29 (0.03) 1.30 (0.03) 3.7 (0.04) 3.7 (0.03) 69.3 (0.7) 69.1 (0.7)
16–20 177.7 (3.7) 175.8 (3.7) 137.4 (2.5) 136.0 (2.6) 1.33 (0.03) 1.33 (0.03) 3.8 (0.04) 3.7 (0.04) 68.3 (0.7) 68.1 (0.8)
>20 178.9 (4.5) 176.8 (4.5) 140.7 (3.1) 139.8 (3.1) 1.29 (0.04) 1.29 (0.04) 3.8 (0.05) 3.7 (0.05) 69.9 (0.9) 69.8 (0.9)
P-trend 0.13 0.19 0.03 0.04 0.38 0.32 0.90 0.94 0.15 0.17
Per 5 years 1.4 (0.9) 1.2 (0.9) 1.3 (0.6) 1.3 (0.6) 20.006 (0.01) 20.007 (0.01) 0.001 (0.01) 20.001 (0.01) 20.3 (0.1) 20.2 (0.2)
Model 1 simultaneously adjusts for waist circumference at year 25 (cm) and duration of abdominal obesity (years) as well as age, sex, race, educational attainment, height,
study center, current smoking, and average physical activity and alcohol intake during follow-up.
aAbdominal obesity defined as a waist circumference >102 cm in men and >88 cm in women.
bCut-points were 86.0, 92.5, 98.3, and 105.5 cm for men and 74.3, 81.5, 89.5, and 97.5 cm for women.
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in the current study, and did not account for the degree of adiposity.
In a small, clinic-based sample of morbidly obese patients prior to
weight loss surgery, Alpert et al. (11) showed the duration of mor-
bid obesity correlated significantly with a higher LV mass and
poorer LV systolic function. In a sample of 35 obese patients, a lon-
ger duration of obesity was associated with LV enlargement and
wall thickening independent of body weight (12). However, among
109 overweight and obese adults attending a weight management
center, the duration of obesity showed no association with numerous
measures of LV structure and function (14). In the current study, we
found a longer duration of overall obesity was associated with a
greater LV mass independent of the degree of adiposity, potential
confounders, and intermediate factors. Our findings suggest that
while the degree of adiposity may be a more important determinant
of cardiac structure in midlife, the long-term cumulative effects of
sustained obesity and metabolic dysregulation during young adult-
hood may also contribute to concentric remodeling primarily by
increasing LV mass.
In the current study, we found significant, positive associations of
the degree of overall and abdominal adiposity with ejection fraction
that were independent of the duration of obesity, potential confound-
ers, and risk factors. Conversely, we observed an inverse association
of a longer duration of overall obesity with a lower ejection fraction
that approached statistical significance. Findings from available
studies of the degree of adiposity with LV systolic function have
varied considerably suggesting that ejection fraction is lower (28),
similar (29), or higher (30) among obese subjects as compared to
those who are not obese. Existing studies of the duration of obesity
have generally shown consistent inverse associations of prolonged
obesity with reduced fractional shortening (11), stroke volume (12),
and ejection fraction (13). Findings from the current study suggest
that there may be a compensatory increase in systolic function in
middle-age with a greater degree of adiposity that may subsequently
become impaired with a longer duration of obesity. Future studies
are needed to confirm these findings particularly with more sensitive
indicators of LV contractile function.
In addition to the increased cardiac work load and resultant
increased LV mass that occurs to meet the enhanced metabolic
demands of both lean and fat mass with obesity, a number of other
potential mechanisms may help to explain the association of a
greater degree of adiposity with structural and functional changes in
the heart. Intra-abdominal fat located in close proximity to the portal
circulation may mediate concentric LV remodeling by secreting a
number of proinflammatory cytokines that may play a role in the
myocardial remodeling process by directly influencing hypertrophy,
fibrosis, and ultimately contractility (31,32). Hyperinsulinemia and
insulin resistance, which may promote myocardial hypertrophy via
the growth-stimulating effects of insulin, may also mediate the
increased LV mass and LA size in obesity (14,33). Obstructive sleep
apnea may also contribute to LV structural changes by exacerbating
daytime and nighttime hypertension, increased sympathetic tone, and
chronic hypoxemia (34). Additional mechanisms that may explain,
at least in part, the association of a greater degree of adiposity with
LV concentric remodeling include increases in leptin and angioten-
sin II, and reductions in adiponectin (35-37). The cumulative effects
of these hemodynamic and metabolic changes as a result of pro-
longed obesity may also help to at least partially explain the associa-
tion of a longer duration of overall obesity with increases in LV
mass and impaired systolic function over time.
Strengths of the current study include a community-based sampling
method; cohort recruitment and follow-up largely during the obesity
epidemic of the last three decades; a biracial cohort; extensive data
on potential confounders; a large sample size well balanced with
respect to age, sex, race, and education that increased precision and
permitted simultaneous adjustment and stratification by multiple var-
iables; repeated assessments of BMI, waist circumference, and
potential confounding factors; a high retention rate; and the standar-
dized data collection protocols and rigorous quality control of the
CARDIA study. Nevertheless, three limitations deserve mention.
First, our study relied on relatively simple estimates of anthropome-
try that are unable to distinguish between fat and fat-free mass.
However, these measures are reliable, efficient, cost-effective, and
widely applicable for research in large studies and clinical practice.
Second, our estimation of the duration of overall and abdominal
obesity during follow-up was based on the measurement of BMI and
waist circumference, respectively, every 2-5 years. It is likely that a
more frequent number of assessments would have led to a more
accurate estimation of the duration of obesity during follow-up.
Third, since our study collected data over a 25-year follow-up
period, some participants were missing at least one eligible measure-
ment of BMI and waist circumference. However, we noted similar
results between our multiple imputed datasets and our primary
dataset.
In conclusion, in this community-based longitudinal cohort study of
adults recruited and followed during the obesity epidemic over the
last three decades in the United States, we found the degree of over-
all and abdominal adiposity to be important factors associated with
a greater LA dimension and a pattern of LV concentric remodeling.
These findings were independent of the duration of obesity and
numerous potential confounding factors and cardiovascular risk fac-
tors. A longer duration of overall obesity, on the other hand, was
associated with a greater left ventricular mass and a trend for a
lower ejection fraction. Thus, these findings suggest that cardiac
remodeling throughout young adulthood results largely as a conse-
quence of a greater degree of adiposity, while the cumulative effects
of a longer duration of overall obesity may contribute to concentric
remodeling predominately by increasing LV mass. Future public
health interventions focused on cardiovascular disease prevention
should focus on younger populations in order to prevent or at least
delay the onset of obesity.O
VC 2014 The Obesity Society
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